Track Nyxoah SA Ordinary Shares — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Nyxoah SA Ordinary Shares NYXH · Stock Open Nyxoah SA Ordinary Shares in new tab

1.33 USD
Add to portfolio
EPS
-2.12
P/B
1.42
ROE
-122.68
Beta
0.96
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateNov. 5, 2026
EPS-2.12
Book Value0.97
Price to Book1.42
Debt/Equity72.18
% Insiders33.191%
Growth
Revenue Growth4.73%
Estimates
Forward P/E-1.64
Forward EPS-0.84

DCF Valuation

Tweak assumptions to recompute fair value for Nyxoah SA Ordinary Shares (NYXH)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Nyxoah SA Ordinary Shares Analysis (NYXH)

Belgium Health Care Stock

Is Nyxoah SA Ordinary Shares a good investment? Nyxoah SA Ordinary Shares (NYXH) is currently trading at 1.33 USD.

Earnings Schedule: Nyxoah SA Ordinary Shares is expected to release its next earnings report on Nov. 5, 2026. The market consensus estimate for Forward EPS is -0.84.

Investor FAQ

Does Nyxoah SA Ordinary Shares pay a dividend?

No, it does not currently pay a dividend.

What asset class is Nyxoah SA Ordinary Shares?

Nyxoah SA Ordinary Shares is classified as a Stock.

When is the next earnings date?

The next earnings date is projected to be Nov. 5, 2026. The company currently has a trailing EPS of -2.12.

Company Profile

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Trades
No dividend information available for this instrument.

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion